| Name | Title | Contact Details |
|---|
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.
Get relief today in the Phoenix Area! We treat whiplash, knee, back, shoulder, joint pain and more! No narcotics, no surgery, just relief!
At Forme, we specialize in designing and manufacturing innovative and high-quality health and wellness products. Our extensive range includes sports nutrition, weight loss supplements, and vitamins to support overall wellbeing. We are dedicated to prov...
Viemed is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed`s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using cutting edge technology.
Ashwood Retirement and Assisted is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.